SCHEMBL3017082

SCHEMBL3017082

COc1ccc(S(=O)(=O)C2CCN(c3nc(Cc4ccc(Cl)cc4)cs3)CC2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
MAPK1 P28482 2/20 0.39
MAPT P10636 5/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
AVPR1B P47901 1/20 0.38
SMPD3 Q9NY59 1/20 0.38
HTR7 P34969 1/20 0.37
EP300 Q09472 1/20 0.37
HIF1A Q16665 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.37
TP53 P04637 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3014222 0.95 MAPT (0.43) GAAMAPK1MAPTALDH1A1KDM4E
SCHEMBL3007606 0.94 KDM4E (0.40) GAAMAPK1MAPTALDH1A1KDM4E
SCHEMBL3014450 0.93 KDM4E (0.41) MAPTALDH1A1KDM4EAVPR1BSMN1; SMN2
SCHEMBL3002803 0.92 KDM4E (0.48) GAAMAPTALDH1A1KDM4EAVPR1B
SCHEMBL3002775 0.92 KDM4E (0.40) MAPTALDH1A1KDM4EAVPR1BSMPD3
SCHEMBL3012725 0.92 AVPR1B (0.40) GAAMAPK1MAPTKDM4EAVPR1B
SCHEMBL3021664 0.91 ERBB2 (0.40) GAAMAPTKDM4EAVPR1BHTR7
SCHEMBL3009492 0.91 POLB (0.41) MAPK1MAPTKDM4EAVPR1BHTR7
SCHEMBL3005904 0.91 ALDH1A1 (0.39) GAAMAPK1MAPTALDH1A1KDM4E
SCHEMBL3007810 0.90 AVPR1B (0.41) MAPTKDM4EAVPR1BEP300HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA GAA 110/4885MAPK1 2767/4885MAPT 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.